+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Healthcare Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Medical Devices, Pharmaceutical), By End-use (Medical Device Companies), By Region, And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 175 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 5415419
Description Jump to:
The global healthcare contract manufacturing market size is expected to reach USD 347.5 billion by 2030, expanding at a CAGR of 9.5% during the forecast period, according to this report. The changing regulatory landscape coupled with rising offshoring to emerging countries is anticipated to propel the healthcare contract manufacturing market growth over the forecast period. For instance, in June 2023, FUJIFILM Diosynth Biotechnologies announced to have a commercial office in Tokyo, offering contract development and manufacturing services for advanced therapies and biologics to Asian pharmaceutical and biotechnology companies.

Due to the emergence of infections, such as COVD-19 many organizations are attempting to accelerate production to meet the growing demand. Thus, these companies are appointing healthcare CMOs to speed up their production processes, as well as reduce their overall costs to meet the increasing demand for medical products. The worldwide effort to develop a vaccine and therapeutic agent against COVID-19 has created the greatest opportunity for many large as well as small CMOs as the pharmaceutical companies are manufacturing vaccine doses on large scale. Hence, the pandemic had a positive impact on this industry.

Increasing demand for advanced products is another factor driving the industry scale. Original Equipment Manufacturers (OEMs) are outsourcing the manufacturing activities of medical devices to third parties, mainly in developing countries to gain economic benefits. Furthermore, these regions are witnessing rising cases of chronic conditions such as heart disorders, thereby positively affecting the market growth. Changes in reimbursement schemes are some of the major factors anticipated to increase the adoption of cost containment measures by OEMs. For instance, to prevent reimbursement issues from impacting financing goals, device manufacturers are developing a well-planned reimbursement strategy in parallel with their regulatory and clinical strategies in the early phases of product development.

Healthcare Contract Manufacturing Market Report Highlights

  • The pharmaceutical segment dominated the market with a share of 65.1% in 2022 owing to a low manufacturing budget and highly sophisticated contract manufacturing service offerings
  • The medical devices segment is expected to be the fastest-growing segment with a CAGR of 9.7% owing to increasing pressure on OEMs to reduce costs and enhance the timeline for taking a product to market
  • Cardiology is the dominant category in the medical device contract manufacturing segment, with a revenue share of 20.6% in 2022, owing to the rising demand for cardiovascular devices as a result of the increasing prevalence of associated heart conditions
  • Asia Pacific is expected to witness lucrative growth of 10.6% from 2023 to 2030, owing to the presence of a large number of service providers, lower costs, and growing demand for medical devices in the region
  • Based on end use segment, the pharmaceutical and biopharmaceutical companies category held the highest revenue share of 55.6% in 2022. High segment shares are mainly due to the increasing rate of biologics approval across the globe, thereby boosting demand for its bulk production contract manufacturing services


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology And Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.1.2. Type
1.1.3. End Use
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective-1
1.4.2. Objective-2
1.4.3. Objective-3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Healthcare Contract Manufacturing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Implementation of international standards by contract manufacturers
3.2.1.2. Drug shortage driving the demand for pharmaceutical development
3.2.1.3. Commercial success of biologics for clinical use
3.2.2. Market Restraint Analysis
3.2.2.1. Regulatory and legal compliance
3.2.2.2. Threat of information loss
3.2.3. Industry Challenges
3.2.3.1. Managing relationships
3.3. Healthcare Contract Manufacturing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat Of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Healthcare Contract Manufacturing Market: Type Segment Analysis
4.1 Healthcare Contract Manufacturing: Market Share Analysis, 2022 & 2030
4.2 Medical Device
4.2.1 Medical device market, 2018 - 2030 (USD Million)
4.2.2 Service
4.2.2.1 Accessories manufacturing
4.2.2.1.1 Accessories manufacturing market, 2018 - 2030 (USD Million)
4.2.2.2 Assembly manufacturing
4.2.2.2.1 Assembly manufacturing market, 2018 - 2030 (USD Million)
4.2.2.3 Component manufacturing
4.2.2.3.1 Component manufacturing market, 2018 - 2030 (USD Million)
4.2.2.4 Device manufacturing
4.2.2.4.1 Device manufacturing market, 2018 - 2030 (USD Million)
4.2.3 Therapeutic area
4.2.3.1 Cardiology
4.2.3.1.1 Cardiology market, 2018 - 2030 (USD Million)
4.2.3.2 Diagnostic imaging
4.2.3.2.1 Diagnostic imaging market, 2018 - 2030 (USD Million)
4.2.3.3 Orthopedic
4.2.3.3.1 Orthopedic market, 2018 - 2030 (USD Million)
4.2.3.4 IVD
4.2.3.4.1 IVD market, 2018 - 2030 (USD Million)
4.2.3.5 Ophthalmic
4.2.3.5.1 Ophthalmic market, 2018 - 2030 (USD Million)
4.2.3.6 General & plastic surgery
4.2.3.6.1 General & plastic surgery market, 2018 - 2030 (USD Million)
4.2.3.7 Drug delivery
4.2.3.7.1 Drug delivery market, 2018 - 2030 (USD Million)
4.2.3.8 Dental
4.2.3.8.1 Dental market, 2018 - 2030 (USD Million)
4.2.3.9 Endoscopy
4.2.3.9.1 Endoscopy market, 2018 - 2030 (USD Million)
4.2.3.10 Diabetes care
4.2.3.10.1 Diabetes care market, 2018 - 2030 (USD Million)
4.2.3.11 Others
4.2.3.11.1 Others market, 2018 - 2030 (USD Million)
4.3 Pharmaceutical
4.3.1 Pharmaceutical market, 2018 - 2030 (USD Million)
4.3.2 Service
4.3.2.1 API/bulk drugs
4.3.2.1.1 API/bulk drugs market, 2018 - 2030 (USD Million)
4.3.2.2 Advanced drug delivery formulations
4.3.2.2.1 Advanced drug delivery formulations market, 2018 - 2030 (USD Million)
4.3.2.3 Packaging
4.3.2.3.1 Packaging market, 2018 - 2030 (USD Million)
4.3.2.4 Finished dose formulations
4.3.2.4.1 Finished dose formulations market, 2018 - 2030 (USD Million)
4.3.2.4.2 Solid
4.3.2.4.2.1 Solid market, 2018 - 2030 (USD Million)
4.3.2.4.3 Liquid
4.3.2.4.3.1 Liquid market, 2018 - 2030 (USD Million)
4.3.2.4.4 Semisolid formulations
4.3.2.4.4.1 Semisolid formulations market, 2018 - 2030 (USD Million)
Chapter 5. Healthcare Contract Manufacturing Market: End Use Segment Analysis
5.1 Healthcare Contract Manufacturing: Market Share Analysis, 2022 & 2030
5.2 Medical Device Companies
5.2.1 Medical device companies market, 2018 - 2030 (USD Million)
5.3 Pharmaceutical & Biopharmaceutical Companies
5.3.1 Pharmaceutical & Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
5.4 Others
5.4.1 Others market, 2018 - 2030 (USD Million)
Chapter 6. Healthcare Contract Manufacturing Market: Regional Analysis
6.1. Regional Market Share Analysis, 2022 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. North America
6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
6.5. Europe
6.5.1. UK
6.5.1.1. Key Country Dynamics
6.5.1.2. Competitive Scenario
6.5.1.3. Regulatory Framework
6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
6.5.2. Germany
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
6.5.3. France
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
6.5.4. Italy
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
6.5.5. Spain
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
6.5.6. Denmark
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
6.5.7. Sweden
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
6.5.8. Norway
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
6.5.9. Belgium
6.5.9.1. Key Country Dynamics
6.5.9.2. Competitive Scenario
6.5.9.3. Regulatory Framework
6.5.9.4. Belgium Market Estimates and Forecasts, 2018 - 2030
6.5.10. Netherlands
6.5.10.1. Key Country Dynamics
6.5.10.2. Competitive Scenario
6.5.10.3. Regulatory Framework
6.5.10.4. Netherlands Market Estimates and Forecasts, 2018 - 2030
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key Country Dynamics
6.6.1.2. Competitive Scenario
6.6.1.3. Regulatory Framework
6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
6.6.2. India
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
6.6.4. South Korea
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
6.6.6. Thailand
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
6.6.7. Philippines
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Philippines Market Estimates and Forecasts, 2018 - 2030
6.6.8. Malaysia
6.6.8.1. Key Country Dynamics
6.6.8.2. Competitive Scenario
6.6.8.3. Regulatory Framework
6.6.8.4. Malaysia Market Estimates and Forecasts, 2018 - 2030
6.6.9. New Zealand
6.6.9.1. Key Country Dynamics
6.6.9.2. Competitive Scenario
6.6.9.3. Regulatory Framework
6.6.9.4. New Zealand Market Estimates and Forecasts, 2018 - 2030
6.6.10. Singapore
6.6.10.1. Key Country Dynamics
6.6.10.2. Competitive Scenario
6.6.10.3. Regulatory Framework
6.6.10.4. Singapore Market Estimates and Forecasts, 2018 - 2030
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key Country Dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory Framework
6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
6.7.2. Mexico
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
6.7.4. Colombia
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
6.7.5. Chile
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030
6.8. MEA
6.8.1. South Africa
6.8.1.1. Key Country Dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory Framework
6.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
6.8.2. Saudi Arabia
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
6.8.3. UAE
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
6.8.4. Kuwait
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
6.8.5. Israel
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Israel Market Estimates and Forecasts, 2018 - 2030
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.1.1. Innovators
7.1.2. Market Leaders
7.1.3. Emerging Players
7.1.4. Company Market Share Analysis, 2022
7.2. Company Profiles
7.2.1 Nordson Corporation.
7.2.1.1 Company overview
7.2.1.2 Financial performance
7.2.1.3 Service benchmarking
7.2.1.4 Strategic initiatives
7.2.2 Integer Holdings Corporation
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Service benchmarking
7.2.2.4 Strategic initiatives
7.2.3 Jabil Inc.
7.2.3.1 Company overview
7.2.3.2 Financial performance
7.2.3.3 Service benchmarking
7.2.3.4 Strategic initiatives
7.2.4 Viant Technology LLC
7.2.4.1 Company overview
7.2.4.2 Service benchmarking
7.2.4.3 Strategic initiatives
7.2.5 FLEX LTD.
7.2.5.1 Company overview
7.2.5.2 Financial performance
7.2.5.3 Service benchmarking
7.2.5.4 Strategic initiatives
7.2.6 Celestica Inc.
7.2.6.1 Company overview
7.2.6.2 Financial performance
7.2.6.3 Service benchmarking
7.2.6.4 Strategic initiatives
7.2.7 Sanmina Corporation
7.2.7.1 Company overview
7.2.7.2 Financial performance
7.2.7.3 Service benchmarking
7.2.7.4 Strategic initiatives
7.2.8 Plexus Corp.
7.2.8.1 Company overview
7.2.8.2 Financial performance
7.2.8.3 Service benchmarking
7.2.8.4 Strategic initiatives
7.2.9 Phillips-Medisize
7.2.9.1 Company overview
7.2.9.2 Service benchmarking
7.2.9.3 Strategic initiatives
7.2.10 West Pharmaceutical Services, Inc.
7.2.10.1 Company overview
7.2.10.2 Financial performance
7.2.10.3 Service benchmarking
7.2.10.4 Strategic initiatives
7.2.11 Synecco Ltd.
7.2.11.1 Company overview
7.2.11.2 Service benchmarking
7.2.12 Catalent, Inc.
7.2.12.1 Company overview
7.2.12.2 Financial performance
7.2.12.3 Service benchmarking
7.2.12.4 Strategic initiatives
7.2.13 Thermo Fisher Scientific Inc.
7.2.13.1 Company overview
7.2.13.2 Financial performance
7.2.13.3 Service benchmarking
7.2.13.4 Strategic initiatives
7.2.14 Recipharm AB.
7.2.14.1 Company overview
7.2.14.2 Financial performance
7.2.14.3 Service benchmarking
7.2.14.4 Strategic initiatives
7.2.15 Boehringer Ingelheim International GmbH
7.2.15.1 Company overview
7.2.15.2 Financial performance
7.2.15.3 Service benchmarking
7.2.15.4 Strategic initiatives
7.2.16 Lonza
7.2.16.1 Company overview
7.2.16.2 Financial performance
7.2.16.3 Service benchmarking
7.2.16.4 Strategic initiatives
7.2.17 Samsung Biologics
7.2.17.1 Company overview
7.2.17.2 Financial performance
7.2.17.3 Service benchmarking
7.2.17.4 Strategic initiatives
7.2.18 WuXi AppTec
7.2.18.1 Company overview
7.2.18.2 Financial performance
7.2.18.3 Service benchmarking
7.2.18.4 Strategic initiatives
7.2.19 FUJIFILM Diosynth Biotechnologies
7.2.19.1 Company overview
7.2.19.2 Financial performance
7.2.19.3 Service benchmarking
7.2.19.4 Strategic initiatives
7.2.20 Cambrex Corporation
7.2.20.1 Company overview
7.2.20.2 Financial performance
7.2.20.3 Service benchmarking
7.2.20.4 Strategic initiatives
Chapter 8. KoL Commentary/Recommendations
List of Tables
Table 1: List of secondary sources
Table 2: List of Abbreviations
Table 3: North America Healthcare Contract Manufacturing market, by Countries, 2018-2030 (USD Million)
Table 4: North America Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 5: North America Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 6: U.S. Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 7: U.S. Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 8: Canada Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 9: Canada Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 10: Europe Healthcare Contract Manufacturing market, by Countries, 2018-2030 (USD Million)
Table 11: Europe Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 12: Europe Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 13: UK Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 14: UK Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 15: Germany Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 16: Germany Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 17: France Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 18: France Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 19: Italy Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 20: Italy Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 21: Spain Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 22: Spain Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 23: Denmark Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 24: Denmark Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 25: Sweden Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 26: Sweden Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 27: Norway Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 28: Norway Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 29: Belgium Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 30: Belgium Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 31: Netherlands Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 32: Netherlands Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 33: Asia Pacific Healthcare Contract Manufacturing market, by Countries, 2018-2030 (USD Million)
Table 34: Asia Pacific Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 35: Asia Pacific Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 36: China Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 37: China Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 38: Japan Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 39: Japan Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 40: India Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 41: India Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 42: Australia Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 43: Australia Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 44: South Korea Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 45: South Korea Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 46: Philippines Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 47: Philippines Healthcare Contract Manufacturing market, by Therapeutic Area, 2018-2030 (USD Million)
Table 48: Malaysia Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 49: Malaysia Healthcare Contract Manufacturing market, by Therapeutic Area, 2018-2030 (USD Million)
Table 50: Thailand Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 51: Thailand Healthcare Contract Manufacturing market, by Therapeutic Area, 2018-2030 (USD Million)
Table 52: New Zealand Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 53: New Zealand Healthcare Contract Manufacturing market, by Therapeutic Area, 2018-2030 (USD Million)
Table 54: Singapore Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 55: Singapore Healthcare Contract Manufacturing market, by Therapeutic Area, 2018-2030 (USD Million)
Table 56: Latin America Healthcare Contract Manufacturing market, by Countries, 2018-2030 (USD Million)
Table 57: Latin America Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 58: Latin America Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 59: Brazil Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 60: Brazil Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 61: Mexico Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 62: Mexico Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 63: Argentina Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 64: Argentina Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 65: Colombia Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 66: Colombia Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 67: Chile Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 68: Chile Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 69: Middle East and Africa Healthcare Contract Manufacturing market, by Countries, 2018-2030 (USD Million)
Table 70: Middle East and Africa Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 71: Middle East and Africa Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 72: South Africa Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 73: South Africa Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 74: Saudi Arabia Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 75: Saudi Arabia Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 76: UAE Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 77: UAE Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 78: Israel Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 79: Israel Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
Table 80: Kuwait Healthcare Contract Manufacturing market, by Type, 2018-2030 (USD Million)
Table 81: Kuwait Healthcare Contract Manufacturing market, by End use, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market research process
Fig. 2: Information procurement
Fig. 3: Market research approaches
Fig. 4: QFD modelling for market share assessment
Fig. 5: Market formulation & validation
Fig. 6: Commodity flow analysis
Fig. 7: Primary research pattern
Fig. 8: Primary interviews in North America
Fig. 9: Primary interviews in Europe
Fig. 10: Primary interviews in Asia Pacific
Fig. 11: Primary interviews in Latin America
Fig. 12: Primary interviews in MEA
Fig. 13: Market Snapshot
Fig. 14: Segment Snapshot
Fig. 15: Competitive Landscape Snapshot
Fig. 16: Healthcare Contract Manufacturing market segmentation
Fig. 17: Parent market outlook (2022)
Fig. 18: Related/ancillary market outlook (2022)
Fig. 19: Market driver relevance analysis (Current & future impact)
Fig. 20: Current shared End uses and outsourcing usage levels
Fig. 21: Market restraint relevance analysis (Current & future impact)
Fig. 22: Porter’s five forces analysis
Fig. 23: SWOT analysis, by a factor (political & legal, economic and technological)
Fig. 24: Healthcare Contract Manufacturing Market Type outlook: Segment dashboard
Fig. 25: Healthcare Contract Manufacturing : Type movement analysis
Fig. 26: Medical devices market, 2018-2030 (USD Million)
Fig. 27: Medical devices market, by service, 2018-2030 (USD Million)
Fig. 28: Accessories manufacturing market, 2018-2030 (USD Million)
Fig. 29: Assembly manufacturing market, 2018-2030 (USD Million)
Fig. 30: Component manufacturing market, 2018-2030 (USD Million)
Fig. 31: Device manufacturing market, 2018-2030 (USD Million)
Fig. 32: Medical devices market, by Therapeutic Area, 2018-2030 (USD Million)
Fig. 33: Cardiology market, 2018-2030 (USD Million)
Fig. 34: Diagnostic imaging market, 2018-2030 (USD Million)
Fig. 35: Orthopedic market, 2018-2030 (USD Million)
Fig. 36: IVD market, 2018-2030 (USD Million)
Fig. 37: Ophthalmic market, 2018-2030 (USD Million)
Fig. 38: General & plastic surgery market, 2018-2030 (USD Million)
Fig. 39: Drug delivery market, 2018-2030 (USD Million)
Fig. 40: Dental market, 2018-2030 (USD Million)
Fig. 41: Endoscopy market, 2018-2030 (USD Million)
Fig. 42: Diabetes care market, 2018-2030 (USD Million)
Fig. 43: Others market, 2018-2030 (USD Million)
Fig. 44: Pharmaceuticals market, 2018-2030 (USD Million)
Fig. 45: Pharmaceuticals market, by Service, 2018-2030 (USD Million)
Fig. 46: API/Bulk Drugs market, 2018-2030 (USD Million)
Fig. 47: Advanced drug delivery formulations market, 2018-2030 (USD Million)
Fig. 48: Packaging market, 2018-2030 (USD Million)
Fig. 49: Finished dose formulation market, 2018-2030 (USD Million)
Fig. 50: Finished dose formulation market, by type, 2018-2030 (USD Million)
Fig. 51: Solid market, 2018-2030 (USD Million)
Fig. 52: Liquid market, 2018-2030 (USD Million)
Fig. 53: Semi-solid formulations market, 2018-2030 (USD Million)
Fig. 54: Healthcare Contract Manufacturing Market End use outlook: Segment dashboard
Fig. 55: Healthcare Contract Manufacturing : End use movement analysis
Fig. 56: Medical device companies market, 2018-2030 (USD Million)
Fig. 57: Pharmaceutical & Biopharmaceutical Companies market, 2018-2030 (USD Million)
Fig. 58: Others market, 2018-2030 (USD Million)
Fig. 59: Regional marketplace: Segment dashboard
Fig. 60: Regional outlook, 2022 & 2030
Fig. 61: North America market, 2018-2030 (USD Million)
Fig. 62: U.S. market, 2018-2030 (USD Million)
Fig. 63: Canada market, 2018-2030 (USD Million)
Fig. 64: Europe market, 2018-2030 (USD Million)
Fig. 65: Germany market, 2018-2030 (USD Million)
Fig. 66: UK market, 2018-2030 (USD Million)
Fig. 67: France market, 2018-2030 (USD Million)
Fig. 68: Italy market, 2018-2030 (USD Million)
Fig. 69: Spain market, 2018-2030 (USD Million)
Fig. 70: Denmark market, 2018-2030(USD Million)
Fig. 71: Sweden market, 2018-2030 (USD Million)
Fig. 72: Norway market, 2018-2030 (USD Million)
Fig. 73: Belgium market, 2018-2030 (USD Million)
Fig. 74: Netherlands market, 2018-2030 (USD Million)
Fig. 75: Asia Pacific market, 2018-2030 (USD Million)
Fig. 76: China market, 2018-2030 (USD Million)
Fig. 77: Japan market, 2018-2030 (USD Million)
Fig. 78: India market, 2018-2030 (USD Million)
Fig. 79: Australia market, 2018-2030 (USD Million)
Fig. 80: South Korea market, 2018-2030 (USD Million)
Fig. 81: Thailand market, 2018-2030 (USD Million)
Fig. 82: Philippines market, 2018-2030 (USD Million)
Fig. 83: Malaysia market, 2018-2030 (USD Million)
Fig. 84: New Zealand market, 2018-2030 (USD Million)
Fig. 85: Singapore market, 2018-2030 (USD Million)
Fig. 86: Latin America market, 2018-2030 (USD Million)
Fig. 87: Brazil market, 2018-2030 (USD Million)
Fig. 88: Mexico market, 2018-2030 (USD Million)
Fig. 89: Argentina market, 2018-2030 (USD Million)
Fig. 90: Colombia market, 2018-2030 (USD Million)
Fig. 91: Chile market, 2018-2030 (USD Million)
Fig. 92: Middle East & Africa market, 2018-2030 (USD Million)
Fig. 93: South Africa market, 2018-2030 (USD Million)
Fig. 94: Saudi Arabia market, 2018-2030 (USD Million)
Fig. 95: UAE market, 2018-2030 (USD Million)
Fig. 96: Kuwait market, 2018-2030 (USD Million)
Fig. 97: Israel market, 2018-2030 (USD Million)

Companies Mentioned

  • Nordson Corporation.
  • Integer Holdings Corporation
  • Jabil Inc.
  • Viant Technology LLC
  • FLEX LTD.
  • Celestica Inc.
  • Sanmina Corporation
  • Plexus Corp.
  • Phillips-Medisize
  • West Pharmaceutical Services, Inc.
  • Synecco Ltd.
  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • Recipharm AB.
  • Boehringer Ingelheim International GmbH
  • Lonza
  • Samsung Biologics
  • WuXi AppTec
  • FUJIFILM Diosynth Biotechnologies
  • Cambrex Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages175
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 171 Billion
Forecasted Market Value ( USD ) by 2030 $ 347.5 Billion
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Services (Contract Development, Contract Manufacturing), By Region, And Segment Forecasts, 2023-2030 - Product Image

Healthcare Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Services (Contract Development, Contract Manufacturing), By Region, And Segment Forecasts, 2023-2030

  • Report
  • 175 Pages
  • Global
From
Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Services (Clinical Monitoring, Data Management), By Region, And Segment Forecasts, 2023-2030 - Product Image

Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Services (Clinical Monitoring, Data Management), By Region, And Segment Forecasts, 2023-2030

  • Report
  • 175 Pages
  • Global
From
Global Healthcare Contract Development & Manufacturing Organization Market by Services, End-User - Forecast 2024-2030 - Product Image

Global Healthcare Contract Development & Manufacturing Organization Market by Services, End-User - Forecast 2024-2030

  • Report
  • 196 Pages
  • Global
From
Global Healthcare Contract Research Organization Market by Type (Clinical, Drug Discovery, Pre-Clinical), Service (Bio-Statistics, Clinical Monitoring, Data Management) - Forecast 2024-2030 - Product Image

Global Healthcare Contract Research Organization Market by Type (Clinical, Drug Discovery, Pre-Clinical), Service (Bio-Statistics, Clinical Monitoring, Data Management) - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Real World Evidence Solution Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Image

Real World Evidence Solution Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • 116 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.